Share to:

COVID-19 Rapid Test

Quantity:

Product characteristics:

The risk of medical staff is small, reducing the probability of droplet infection.

It's fast and takes only 10 minutes to produces results.

No special testing environment and personnel training is required.

Compared with nucleic acid test swabs and pharyngeal swabs, it is less affected by samples and has high accuracy.

Dosage is less, only 1 drop of serum or plasma sample is needed.

Testing IgM and IgG at the same time to reduce the testing time.

Convenient, fast, suitable for mass screening.

 

When the human body is infected with the 2019-nCoV, the first antibody produced is the specific Igm antibody, which is generally produced after 3-7days of infection, and is replaced by a large number of specific IgG antibodies produced about two weeks later. Therefore, IgM and IgG of the 2019-nCoV specific antibodies can be used as an auxiliary means for the diagnosis of suspected patients.(Not Available in the U.S)

 

 

 Models:

Product Name

Specimen

Format

Kit Size

COVID-19 IgM/IgG Ab Rapid Test

WB/S/P

Panel

20T/Box

 


ABOUT BIOBASE

BIOBASE Group  is a new high-tech enterprise focusing on development, production and management of scientific equipment, In Vitro Diagnosis (IVD) instrument and reagent.

CONTACT US

  6th floor, No. 2 building, 9 Gangxing road, High-tech Zone, Jinan, Shandong, China
  +86-531-81219803
  +86-531-81219804

PRODUCT CATEGORY

Copyrights  2020 Biobase Biodusty(Shandong), Co., Ltd.  All rights reserved